PBYI(Puma Biotechnology, Inc.) · 财务报表

PBYI(Puma Biotechnology, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$253.16M$228.03M$235.64M$230.47M$228.37M
毛利润$189.45M$172.94M$172.96M$166.06M$170.21M
营业利润$1.29M$23.72M$32.64M$30.97M$37.30M
净利润−$29.13M$2.00K$21.59M$30.28M$31.11M
经营现金流$20.65M−$15.83M$27.01M$38.92M$41.80M
自由现金流$20.65M−$15.83M$26.87M$38.86M$41.73M
摊薄每股收益$-0.72$0.00$0.45$0.62$0.61

Puma Biotechnology, Inc. PBYI